BNP Paribas Financial Markets’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20.8M | Buy |
|
|||||
|
2025
Q2 | $2.48M | Buy |
|
|||||
|
2025
Q1 | $215K | Sell |
|
|||||
|
2024
Q4 | $240K | Sell |
|
|||||
|
2024
Q3 | $473K | Sell |
|
|||||
|
2024
Q2 | $528K | Sell |
|
|||||
|
2024
Q1 | $1.43M | Buy |
|
|||||
|
2023
Q4 | $553K | Sell |
|
|||||
|
2023
Q3 | $1.05M | Buy |
|
|||||
|
2023
Q2 | $486K | Buy |
|
|||||
|
2023
Q1 | $319K | Buy |
|
|||||
|
2022
Q4 | $235K | Sell |
|
|||||
|
2022
Q3 | $241K | Buy |
|
|||||
|
2022
Q2 | $169K | Sell |
|
|||||
|
2022
Q1 | $163K | Sell |
|
|||||
|
2021
Q4 | $319K | Sell |
|
|||||
|
2021
Q3 | $332K | Buy |
|
|||||
|
2021
Q2 | $165K | Buy |
|
|||||
|
2021
Q1 | $126K | Buy |
|
|||||
|
2020
Q4 | $72.1K | Buy |
|
|||||
|
2020
Q3 | $68.7K | Buy |
|
|||||
|
2020
Q2 | $17.3K | Sell |
|
|||||
|
2020
Q1 | $149K | Buy |
|
|||||
|
2019
Q4 | $127K | Buy |
|
|||||
|
2019
Q3 | $96.5K | Buy |
|
|||||
|
2019
Q2 | $73.6K | Sell |
|
|||||
|
2019
Q1 | $118K | Buy |
|
|||||
|
2018
Q4 | $135 | Sell |
|
|||||
|
2018
Q3 | $15.6K | Hold |
|
|||||
|
2018
Q2 | $18.4K | Sell |
|
|||||
|
2018
Q1 | $154K | Sell |
|
|||||
|
2017
Q4 | $224K | Sell |
|
|||||
|
2017
Q3 | $233K | Buy |
|
|||||
|
2017
Q2 | $101K | Buy |
|
|||||
|
2017
Q1 | $73.7K | Buy |
|
|||||
|
2016
Q4 | $81.7K | Buy |
|
|||||
|
2016
Q3 | $72.2K | Sell |
|
|||||
|
2016
Q2 | $132K | Buy |
|
|||||
|
2016
Q1 | $40.8K | Sell |
|
|||||
|
2015
Q4 | $66.1K | Sell |
|
|||||
|
2015
Q3 | $63.3K | Buy |
|
|||||
|
2015
Q2 | $40.6K | Buy |
|
|||||
|
2015
Q1 | $9.82K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $3.2K | Buy |
|